Difficulty: Medium
Average Score: 85%
Practice
Antibiotic associated-pseudomembranous colitis is most likely to be due to:
Correct answer
C
Rationale
In the context of ABVD chemotherapy drugs, understanding the potential side effects and interactions is crucial for healthcare professionals. In this case, the correct answer is C) Clindamycin. Clindamycin is known to disrupt the normal balance of gut flora, leading to the overgrowth of Clostridium difficile bacteria, which can cause antibiotic-associated pseudomembranous colitis.
Vancomycin (A) is not typically associated with pseudomembranous colitis; it is more commonly used to treat infections caused by gram-positive bacteria. Azithromycin (B) is a macrolide antibiotic that is not as strongly linked to causing pseudomembranous colitis compared to Clindamycin. Metronidazole (D) is actually used in the treatment of Clostridium difficile infections and is not a common cause of pseudomembranous colitis itself.
Educationally, this question highlights the importance of understanding the side effects and potential complications of different antibiotics, especially in the context of chemotherapy where patients may already be immunocompromised. It reinforces the need for healthcare providers to carefully consider the risks and benefits of antibiotic therapy and to monitor patients for adverse effects.
Vancomycin (A) is not typically associated with pseudomembranous colitis; it is more commonly used to treat infections caused by gram-positive bacteria. Azithromycin (B) is a macrolide antibiotic that is not as strongly linked to causing pseudomembranous colitis compared to Clindamycin. Metronidazole (D) is actually used in the treatment of Clostridium difficile infections and is not a common cause of pseudomembranous colitis itself.
Educationally, this question highlights the importance of understanding the side effects and potential complications of different antibiotics, especially in the context of chemotherapy where patients may already be immunocompromised. It reinforces the need for healthcare providers to carefully consider the risks and benefits of antibiotic therapy and to monitor patients for adverse effects.